Zeesan is a biomedical company that specializes in the development and production of molecular diagnostics kits.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 7, 2021 | Post-IPO Equity | $10M | 3 | — | — | Detail |
Jul 28, 2015 | Post-IPO Equity | ¥30.80M | 2 | — | — | Detail |
Feb 19, 2014 | Series A | ¥10M | 1 | — | — | Detail |
Feb 16, 2012 | Angel | ¥5M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Qianhai Dingfeng Investment | — | Post-IPO Equity |
Xuankai Touzi | — | Post-IPO Equity |
Dirui Zichan | — | Post-IPO Equity |
Yinhua Caifu | — | Post-IPO Equity |
Dingfeng Asset | — | Post-IPO Equity |
HY Venture | — | Series A |